Heterogeneity of RNA editing in mesothelioma and how RNA editing enzyme ADAR2 affects mesothelioma cell growth, response to chemotherapy and tumor microenvironment
Preprint
Abstract
We previously observed increased levels of adenosine-deaminase-acting-on-dsRNA (Adar)-dependent RNA editing during mesothelioma development in mice exposed to asbestos. The aim of this study was to characterize and assess the role of ADAR-dependent RNA editing in mesothelioma. Tumors and mesothelioma primary cultures have higher ADAR-mediated RNA editing compared to mesothelial cells. Unsupervised clustering of editing in different genomic regions revealed heterogeneity between tumor samples as well as mesothelioma primary cultures. ADAR2 expression levels are higher in BRCA1-associated protein 1 wild-type tumors, with corresponding changes in RNA editing in transcripts and 3’UTR. ADAR2 knockdown and rescue models indicated a role in cell proliferation, altered cell cycle, increased sensitivity to antifolate treatment and type-1 interferon signaling upregulation, leading to changes in the microenvironment in vivo . Our data indicate that RNA editing contributes to mesothelioma heterogeneity and highlights an important role of ADAR2 not only in growth regulation in mesothelioma but also chemotherapy response, in addition to regulating inflammatory response downstream of sensing nucleic acid structures.Keywords
All Related Versions
- Published version: Molecular Oncology, 16 (22), 3949.
This publication has 100 references indexed in Scilit:
- A-to-I RNA editing: The “ADAR” side of human cancerSeminars in Cell & Developmental Biology, 2012
- The ADAR protein familyGenome Biology, 2012
- The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistanceCell Death & Disease, 2011
- Biases in Illumina transcriptome sequencing caused by random hexamer primingNucleic Acids Research, 2010
- Two physically, functionally, and developmentally distinct peritoneal macrophage subsetsProceedings of the National Academy of Sciences, 2010
- ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signalingNature Immunology, 2008
- TEAD mediates YAP-dependent gene induction and growth controlGenes & Development, 2008
- Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular SpheroidsJournal of Biological Chemistry, 2008
- Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes & Development, 2007
- The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAPCell, 2005